Iacta Alea Est: The Inexorable Advance of Tofacitinib in the Treatment of Dermatomyositis-Associated Rapidly Progressive Interstitial Lung Disease. A Case Report

• Váldodahkkit: Walter Conca (Dahkki), Ihab Weheba (Dahkki), Mohei-Eldin Abouzied (Dahkki), Abeer Abdelsayed (Dahkki), Yousif Aleyouni (Dahkki), Eid Al‐Mutairy (Dahkki), Nasir Bakshi (Dahkki), Mohammad Khalid (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: Frontiers Media S.A., 2020-12-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

Rapidly progressive interstitial lung disease is typically associated with clinically amyopathic dermatomyositis and the anti-melanoma differentiation associated gene 5 antibody, a condition with high mortality and resistance to classic immunosuppression. Recent reports have described the efficacy o...